Replies to post #149641 on Biotech Values

[jq1234]

Without the need to do separate trials for EMA, EU become an add on to US without incurring much additional development cost. FDA/EMA should harmonize for NDA/BLA/MAA as well to reduce the need to do separate trials for US and EU.